Clinical Trial Update: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial evaluating doxycycline with ursodeoxycholic acid in transthyretin amyloidosis with cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Transthyretin Amyloidosis

Drugs mentioned

• Doxycycline (Doxycycline)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Umeå University | Conditions: Transthyretin Amyloidosis, Cardiomyopathy | Phase 2 | Status: COMPLETED